NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.23) by 13.04 percent. This is a 4.76 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $22.068 million which beat the analyst consensus estimate of $21.644 million by 1.96 percent. This is a 2.02 percent decrease over sales of $22.524 million the same period last year.